VARNOTECH
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. It was founded in 2019.
VARNOTECH
Industry:
Intellectual Property Medical Product Research
Founded:
2019-01-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.varnotech.com.cn
Status:
Active
Total Funding:
730 M CNY
Similar Organizations
ArtisanBio
ArtisanBio is provider of cell engineering and data analysis solutions that advance the cell therapy revolution.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Precision Biotechnology
Precision Biotechnology specializes in the development of immune cell preparations and application technologies for cancer patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vaxess Technologies
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Investors List
Taizhou Huayin Financial Investment
Taizhou Huayin Financial Investment investment in Series B - varnotech
Jincheng Capital
Jincheng Capital investment in Series B - varnotech
Shunxi Fund
Shunxi Fund investment in Series B - varnotech
3E Bioventures
3E Bioventures investment in Series B - varnotech
Beijing Jianxing Yiliao Jiankang Chanye Guquan Touzi Jijin
Beijing Jianxing Yiliao Jiankang Chanye Guquan Touzi Jijin investment in Series B - varnotech
Watere Capital
Watere Capital investment in Series B - varnotech
Legend Capital
Legend Capital investment in Series A - varnotech
IDG Capital
IDG Capital investment in Series A - varnotech
Watere Capital
Watere Capital investment in Seed Round - varnotech
Official Site Inspections
http://www.varnotech.com.cn
- Host name: 8.152.223.120
- IP address: 8.152.223.120
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "varnotech"
varnotech - Crunchbase Company Profile & Funding
Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. It was founded in 2019. Where is varnotech's …See details»
Varnotech Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Varnotech. Use the PitchBook Platform to explore the full profile.See details»
Recombinant Zoster Vaccine (Varnotech) - Drug Targets, …
[Translation] A randomized, blinded, positive-controlled phase II clinical trial to evaluate the immunogenicity and safety of a recombinant herpes zoster vaccine (CHO cells) in people aged …See details»
新型疫苗佐剂技术-新型疫苗佐剂技术-北京华诺泰生物医药科技有 …
拥有新型疫苗佐剂技术、重组蛋白疫苗技术、纳米颗粒疫苗载体技术See details»
Moderna’s latent & public health vaccines: VZV vaccine (mRNA …
May 4, 2022 · Slide 1 Modality Program ID # Preclinical development Phase 1 Phase 2 Phase 3 Commercial Moderna rights CMV vaccine mRNA-1647 Worldwide mRNA-1189 Worldwide …See details»
媒体报道-新闻中心-北京华诺泰生物医药科技有限公司
北京华诺泰生物医药科技有限公司See details»
泰州市领导莅临调研华诺泰带状疱疹疫苗、佐剂生产项目-公司新闻 …
3月12日，泰州市医药高新区党工委委员、管委会副主任，高港区委常委、区政府常务副区长王英俊一行赴生物医药产业园区督导项目建设工作，现场调研了华诺泰带状疱疹疫苗、佐剂生产项 …See details»
重磅∣华诺泰重组带状疱疹疫苗（CHO细胞）获得临床试验批准医药 …
⌈ByDrug医药新闻摘要⌋ 2023-09-25 14:34，VARNOTECH华诺泰：2023年9月25日，华诺泰的重组带状疱疹疫苗收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展预 …See details»
华诺泰生物 | 项目信息-36氪
华诺泰生物是一家具有自主知识产权的人用疫苗和创新佐剂研发及产业化的平台型公司。 在研佐剂产品十余项，包括脂质体、铝、水包油等多种制剂类型，其中核心佐剂组分即将完成药学研究 …See details»
北京华诺泰生物医药科技有限公司_【工商信息_信用信息_纳税人识 …
企业邮箱：wan***@varnotech.com.cn 更多邮箱（4 个） 企业网址：http://www.varnotech.com.cn. 企业地址：北京市北京经济技术开发区科创十四街99号7幢4层2401室See details»
华诺泰 - 企查查
Jan 4, 2019 · 华诺泰是一家创新疫苗及佐剂开发商，华诺泰拥有包括佐剂技术平台、载体技术平台、抗原筛选技术平台等核心技术，其中佐剂技术平台将对国内疫苗领域起到颠覆性作用。See details»
Radionuclide Therapy Developers Attract Investor Attention in …
Apr 4, 2024 · China's Chengdu New Radiomedicine Technology and the radiotherapy CRDMO Mitro Biotech bagged a combined $94m in their respective new financing rounds during …See details»
Varnotech Biopharm - Crunchbase
Varnotech Biopharm engages in the research and development of human vaccine products and innovative adjuvants.See details»
How to make a website run the index.html file? - Stack Overflow
Dec 8, 2017 · If you want to display the contents of an index.html file when a request is made to your website domain, let's say it is domain.com, then all you have to do is to upload the …See details»
How can i change the default "LandingPage ... - Virtualmin …
Oct 9, 2023 · Add a new index.html to /etc/skel/public_html/ (or whatever skel directory you have configured). You should not change anything in the Virtualmin installation directories. Any such …See details»
VarNote Applications - mulinlab.org
To facilitate researchers to execute the job locally as well as systematically compare results with different parameters, VarNote has introduced various annotation and prioritization modules to …See details»
Safety of Human Cells, Tissues and Organs for Transplantation ...
Marginal note: Registration number 7 (1) On review of an application for registration, if the Minister determines that the information provided in the application is complete, the Minister …See details»
Public Money? Public Code! - FSFE
The Public Money?Public Code! campaign aims to set Free Software as the standard for publicly financed software. Public administrations following this principle can benefit from collaboration …See details»